Previous Close | 3.6100 |
Open | 3.6400 |
Bid | 3.6800 x 900 |
Ask | 3.8000 x 1300 |
Day's Range | 3.4500 - 3.7100 |
52 Week Range | 1.6000 - 6.4700 |
Volume | 438,683 |
Avg. Volume | 729,336 |
Market Cap | 231.52M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2300 |
Earnings Date | Mar 29, 2021 - Apr 02, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.71 |
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management is scheduled to participate in two upcoming investor conferences:
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company management will participate in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 10:40 a.m. EST.
Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, will provide a one-time $75 payment to each partner who completes a Covid-19 vaccination program as it becomes available. For each partner that gets fully vaccinated, Petco will also contribute $25 to the Petco Partner Assistance Fund, which provides assistance to employees experiencing financial hardship.